One of Warren Buffett’s favourite maxims is to be greedy when others are fearful and fearful when others are greedy.

Premaitha Health (NIPT) has announced that its IONA test has been approved by Brazil's regulatory authority, Agência Nacional de Vigilância Sanitária (ANVISA), for sale as an in vitro diagnostic test.

As we await today's NAV from, deep in the merde, Woodford Patient Capital Trust (WPCT) as well as possible confirmation its unquoted holdings have surged through the 80% limit as well as potentially news on how close hitis to breaching the bank limit of 20% gearing, it is worth reminding ourselves of one reason why it is in this mess - its high risk approach to leverage. 

I know, I know, you have bigger matters to worry about with the current bout of stock market volatility impacting your wealth. It impacts mine too - especially the 6% fall of my largest holding Randgold Resources (RRS) after a full year results publication that saw record production, lower cash costs, fantastic grade, super sounding prospects... I could go on but regular readers know that I have an almost perma love-up with the FTSE-350's largest pure-play gold producer.

Writing on Accrol Group (ACRL) previously last month, business and management flux saw me remain sceptical. Now a Board Changes announcement…

Hello Share Mashers. After a lot of research and getting three-quarters of the way through a blistering piece on a firm which services other companies, I suddenly had a feeling that the shares would struggle to rise. I was unable to pin down creeping doubt, after my initial enthusiasm, but I abandoned the tip, anyway. Four hours work up the spout! But that’s the worth of this splendid website. We writers like to think we say stuff with real value and integrity. What's a few hours wasted, if we stand a better chance of making you some money? So instead I commend for your further attention a keep-fit enterprise.

As predicted here at the weekend Nasdaq listed Irish biotech Prothena (US:PRTA) is suffering a bloodbath today following the shock after hours resignation of its CMO on Friday. Shares in Purplebricks (PURP) are also crashing and that leaves the Woodford Patient Capital Trust (WPCT) in serious trouble - has it breached its banking limits yet?

In the wake of the recent fund raise by Obtala (OBT), the company's house broker VSA has slashed its price target from 36p to 25p but it is forecasting EPS of 1.6p for calendar 2018 and with massive asset backing, explains in a detailed note out today, why the shares will double from the current  12.625p mid. We own the shares and, for what it is worth, I agree with analyst Edward Hugo.

Secure payment and customer contact technology company Eckoh (ECK) is “very pleased with the recent progress we have made in the UK”, this including that it “has since interim results on November 22nd 2017 secured six sizeable UK contract wins across the payments, insurance, healthcare and mobile telecoms sectors - the latter being a contract with one of the UK's largest mobile network providers”. Significant growth ahoy then? Er…

If history is any guide, the good times are about to end for the U.S. stock market and it’s been one of the longest-running bull markets ever. Over nearly nine years, or 105 months, the S&P 500 has returned 368 percent (including dividends). That’s the second-longest bull market the U.S. has ever seen… just behind the nearly 9.5 year-long, or 113 months, bull market that started in 1990. You can see the S&P 500’s past bull markets in the table below… it shows the date they began, their overall return and how long each lasted. On average since 1926, bull markets have lasted for 54 months, and resulted in returns of 160 percent.

Does Lyin' Steve Sanderson of UK Oil & Gas (UKOG) know what month it is let alone what day of the week it is? I am only asking because of a statement he snuck out when all sane folks were not watching the screen, on December 27 regarding flow testing at Broadford Bridge. Remember that companies - especially those with stacks of death spiral loan notes to convert - hurry out good news and always delay bad news. So rewind to when you and I were focusing on mince pies, the man who specialises in porky pies stated:

Murgitroyd Group (MUR) has announced results for the six months ended 30th November 2017 including “pleased to report half year results in line with management expectations, with an increase in pre-tax profit of 13%”. Sounds good, but what was the comparative again?...

I note that for the first time the NAV of the Woodford Income Focus Fund  (C Accumulation Units) has fallen below the 100p launch and that includes 3 reinvested dividends.

For reasons mainly to do with girls (well two of them) I have always been a Philadelphia Eagles fan. The last time they won a championship, Hurst, Peters and Moore were playing for West Ham - the two teams have a lot in common. Anyhow I stayed up late and for once fortune is not always hiding. Why did I get up? The market is a sea of red and I discuss that. I look at IQE (IQE) after chatting to Matt Earl, at Woodford Patient Capital Trust (WPCT), Inspirit (INSP) and at Shield Therapeutics (STX). Nomates Neil Woodford has not replied to my polite invitation of yesterday. 

IQE (IQE) has, this morning, attempted to hit back at Matt Earl's devastating dossier published on Friday, HERE. The statement, crafted by evil and hugely expensive PR spinners FTI, naturally seeks to point out that Earl's Shadowfall fund is short so gains if the share price goes down. No doubt house broker Stifel which has earned millions from IQE will publish a bullish report later. Will IQE issue an RNS flagging up its COI? No. Earl himself has hit back at the hit back telling ShareProphets:

I have been taking a look through the FCA table of registered short positions, following my piece on Interserve of Friday. I don’t offer anything exhaustive, but the largest individual short positions interested me as they are as high as 5.42% of the capital. That’s quite a bet. Oh, and just as it happens, Neil Woodford features with two of them. They are also all stocks where we at ShareProphets have been bearish.

Hello Share Trackers. From time to time, I’ve suggested you peek at the giant drinks firm Diageo (DGE). The reasons I usually rehearse are basic. The world seems to be on a strengthening booze trail. And if the world’s economy is due a massive correction, as everybody seems to fear, people seem to seek solace in more drinking.

I have today written to Britain's most conceited fund manager Neil Woodford to see whether he dares to stand up for himself and face up to me in public. Here goes

There is no honour among thieves. There is still less amongst those hacks working for the dying industry that is the deadwood press. Step forward City AM and journalist Lucy White who on February 1 at 2.42 PM ran a story with the sub head "The corporate finance firm of former Dragons' Den star Julie Meyer, which was put into administration at the end of last year, owes almost £2m to unpaid employees and advisers, City A.M. can reveal"

Obtala (OBT) has announced an offer of shares at 12.5p via PrimaryBid.com - which closes at 5PM on Sunday or when the book is filled. Hurry - TAKE THIS UP HERE  This follows an earlier Acquisition, Expansion Capital and Fundraising announcement…